FLT4 Protein

Produktnummer ABIN935897

Dieses Recombinant FLT4-Protein wird in Insect cells (Sf9) produziert.

Kurzübersicht für FLT4 Protein (ABIN935897)

Target: FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))

Protein-Typ: Recombinant

Spezies: Human

Quelle: Insect cells (Sf9)

Reinheit: > 90 % pure

Produktdetails

Produktmerkmale: Purified recombinant Human VEGFR3 protein
Expression System: Sf-9 insect cells

Endotoxin-Niveau: < 0.1 ng per g of sVEGFR-3

Anwendungsinformationen

Applikationshinweise: Each Investigator should determine their own optimal working dilution for specific applications.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Rekonstitution: Reconstitute in sterile water to a concentration > 0.1 mg/mL.

Buffer: Supplied as a lyophilized powder with no preservative.

Konservierungsmittel: Without preservative

Handhabung: Avoid repeated freeze/thaw cycles.

Lagerung: -20 °C/-80 °C

Informationen zur Lagerung: Store at -70 °C until reconstitution. Following reconstitution product should be aliquoted and frozen at -20 °C.

Antigendetails

Target: FLT4 (Fms-Related Tyrosine Kinase 4 (FLT4))

Andere Bezeichnung: VEGFR3

Hintergrund: Fms-related tyrosine kinase 4, also known as FLT4, is a protein which in humans is encoded by the FLT4 gene. This gene encodes a tyrosine kinase receptor for vascular endothelial growth factors C and D. The protein is thought to be involved in lymphangiogenesis and maintenance of the lymphatic endothelium. Mutations in this gene cause hereditary lymphedema type IA. .
Alternative Names: FLT4 protein, FLT-4 protein, Vascular Endothelial Growth Factor Receptor 3 protein, VEGF-R3 protein

Molekulargewicht: 120 kDa

Pathways: RTK Signalweg, Signaling Events mediated by VEGFR1 and VEGFR2, VEGF Signaling